Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose
Circular	Director General	66	20-6-2025	Regarding Specialized Mental Health Medications	Circular number 66: Concerning Specialized Mental Health Medications

ATC	Name	B/G	Ingredients	Dosage	Form	Price
H02AB13	DEFAL	B	Deflazacort - 6mg	6mg	Tablet	415,247 L.L
J02AC03	VFEND	B	Voriconazole - 200mg	200mg	Tablet, film coated	51,904,550 L.L
N05AH03	ZYPREXA	B	Olanzapine - 5mg	5mg	Tablet	1,197,364 L.L
N06BA04	CONCERTA	B	Methylphenidate HCl - 36mg	36mg	Tablet, extended release	4,393,021 L.L
S01BA01	OZURDEX	B	Dexamethasone - 700mcg	700mcg	Implant	80,696,540 L.L
L01ED03	ALECENSA	B	Alectinib - 150mg	150mg	Capsule, hard	L.L
A10BD02	GLUCOVANCE	B	Metformin HCl - 500mg, Glibenclamide - 5mg		Tablet, film coated	775,971 L.L
G03BB01	PROVIRON	B	Mesterolone - 25mg	25mg	Tablet	391,058 L.L
H02AB13	DEFAL	B	Deflazacort - 30mg	30mg	Tablet	635,638 L.L
M02AA15	FLECTOR E.P TISSUGEL	B	Diclofenac (epolamine) - 1%	1%	Patch	1,204,083 L.L
N06BA04	CONCERTA	B	Methylphenidate HCl - 54mg	54mg	Tablet, extended release	6,049,979 L.L
S01BA01	OZURDEX	B	Dexamethasone - 700mcg	700mcg	Implant	80,696,540 L.L
B01AC04	PLAVIX	B	Clopidogrel (hydrogenosulfate) - 75mg	75mg	Tablet, film coated	1,350,562 L.L
D04AB01	VERSATIS	B	Lidocaine - 5%	5%	Patch	13,085,712 L.L
G03CA03	OESTRODOSE	B	Estradiol (17 bêta estradiol anhydre) - 0.06%	0.06%	Gel	642,357 L.L
M02AA15	VOLTAREN EMULGEL 12HRS	B	Diclofenac Diethylamine - 23.2mg/g	23.2mg/g	Gel	1,169,143 L.L
N06BA04	CONCERTA	B	Methylphenidate HCl - 18mg	18mg	Tablet, extended release	3,133,841 L.L
S01BA04	PRED FORTE	B	Prednisolone acetate - 10mg/ml	1%	Drops suspension	260,705 L.L
B01AC04	PLAVIX	B	Clopidogrel (hydrogenosulfate) - 75mg	75mg	Tablet, film coated	1,350,562 L.L
C01AA05	LANOXIN PG	B	Digoxin - 0.05mg/ml	0.05mg/ml	Elixir	307,740 L.L
D04AB01	VERSATIS	B	Lidocaine - 5%	5%	Patch	2,772,347 L.L
H03AA01	EUTHYROX	B	Levothyroxine sodium - 25mcg	25mcg	Tablet, scored	256,674 L.L
J01DD15	OMNICEF	B	Cefdinir - 300mg	300mg	Capsule	2,238,842 L.L
J02AC03	V-FEND	B	Voriconazole - 200mg	200mg	Injectable powder for solution	8,078,564 L.L
M02AA15	VOLTAREN EMULGEL 12HRS	B	Diclofenac Diethylamine - 23.2mg/g	23.2mg/g	Gel	717,612 L.L
R03BA05	FLIXOTIDE EVOHALER	B	Fluticasone propionate - 250mcg/actutaion	250mcg/actutaion	Inhalation suspension	1,484,946 L.L
S01BA04	PRED FORTE	B	Prednisolone acetate - 10mg/ml	1%	Drops suspension	260,705 L.L
A04AA01	ZOFRAN INJECTION	B	Ondansetron (HCl dihydrate) - 4mg/2ml	4mg/2ml	Injectable solution	7,280,806 L.L
A10BD02	GLUCOVANCE	B	Metformin HCl - 1000mg, Glibenclamide - 5mg		Tablet, film coated	1,006,220 L.L
C01AA05	LANOXIN	B	Digoxin - 0.25mg	0.25mg	Tablet	215,015 L.L